The United States has signed into law a US$5.88 billion bipartisan spending package aimed at strengthening the global fight against HIV.

Explore the latest advancements in HIV therapy and how enhanced immune cells can improve treatment outcomes for patients.

Broadly neutralizing antibodies, or bnAbs, are a long‑standing goal of HIV vaccine research because they can disable many strains of the virus at once.

More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control ...

More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS).

One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and ...

In Fiji, HIV/AIDS cases are projected to double this year to more than 3,000, according to UNAIDS and Fiji’s Ministry of ...

US President Donald Trump signed the consolidated spending package into law on 3 February 2026 which allocates US$ 4.6 billion to bilateral HIV support through the America First Global Health Strategy ...